MENU

MS & Immune Disorders

About this condition
Patient & Caregiver Tools
Show More
Articles
Multiple Sclerosis Minute: Natalizumab Extended-Interval Dosing image

Columns

Multiple Sclerosis Minute: Natalizumab Extended-Interval Dosing

The extended interval dosing approach for natalizumab treatment reduces the risk of progressive multifocal leukoencephalopathy.

Lana Zhotvis Ryerson

Medical Transition from Pediatric to Adult Care in Neurology image

Cover Focus

Medical Transition from Pediatric to Adult Care in Neurology

It is critical to see transition as a process not simply a moment in time when care is transferred.

Lawrence W. Brown, MD

Antibody-Mediated Inflammatory Central Nervous System Disorders of Childhood image

Cover Focus

Antibody-Mediated Inflammatory Central Nervous System Disorders of Childhood

There is an expanding spectrum of neurologic disease caused by antibody-mediated inflammation that is also seen during childhood.

Duriel I. Hardy, MD, and Sona Narula, MD

March 2020 teaser

Guest Medical Editor's Page

Child Neurology

The scope of child neurology and available treatments for children is expanding.

Donna Stephenson, MD

An Example of the Central Vein Sign image

About The Cover Artist

An Example of the Central Vein Sign

Daniel S. Reich, MD, PhD

Multiple Sclerosis Treatment in Racial and Ethnic Minorities image

Cover Focus

Multiple Sclerosis Treatment in Racial and Ethnic Minorities

Systematic literature review shows little evidence to guide treatment.

Michael V. Robers, MD, Deepak Soneji, MD, PhD, and Lilyana Amezcua, MD, MS

February 2020 teaser

Cover Focus

Point/Counterpoint: Food and Drug Administration Multiple Sclerosis Categorization Changes

Are the changes a step forward or a step back?

Svetlana Primma Eckert, MD, Bianca Weinstock-Guttman, MD, and Stephen Krieger, MD

Drugs in Development for Multiple Sclerosis image

Cover Focus

Drugs in Development for Multiple Sclerosis

Stem cells, tyrosine kinase inhibitors, remyelinating agents, metabolically active molecules, and more are being tested as potential new disease-modifying treatments.

Konstantin Balashov, MD, PhD

Cladribine image

Cover Focus

Cladribine

Cladribine is an effective oral treatment for multiple sclerosis with potential for long-term remission.

Crystal Dixon, MD, Miguel Melo-Bicchi, MD, and Kottil W. Rammohan, MD

AntiCD20+ Agents image

Cover Focus

AntiCD20+ Agents

AntiCD20+ agents are among the highest efficacy treatments for multiple sclerosis.

Brian Barry, MD, and Robert K. Shin, MD

Sphingosine-1-Phosphate Modulators for Multiple Sclerosis image

Cover Focus

Sphingosine-1-Phosphate Modulators for Multiple Sclerosis

Sphingosine-1-phosphate modulators may act through more than just inhibition of neuroimmune and neuroinflammatory effects of multiple sclerosis.

Mark B. Skeen, MD

Point/Counterpoint: Neurofilament Light image

Cover Focus

Point/Counterpoint: Neurofilament Light

Ready for prime time as a biomarker for multiple sclerosis or not?

Adil Javed, MD, PhD, and James Stankiewicz MD, FAAN

The Central Vein Sign image

Cover Focus

The Central Vein Sign

Is 1.5 T MRI still relevant for diagnosis of multiple sclerosis?

Evanthia Bernitsas, MD

February 2020 teaser

Guest Medical Editor's Page

Multiple Sclerosis: Reverse Engineering Continues

Thomas P. Leist, MD

MS Minute: Ibudilast image

Columns

MS Minute: Ibudilast

Ibudilast is a phosphodiesterase inhibitor that has shown some benefit for progressive multiple sclerosis in a phase 2 trial.

Abdul R. Alchaki, MD, and Andrew D. Goodman, MD

Susac Syndrome image

Cover Focus

Susac Syndrome

A triad of encephalopathy, branch retinal artery occlusions, and sensorineural hearing loss.

Ilka Kleffner, MD; Catharina C. Gross, PhD; Marius Ringelstein, MD; Jörg Rehrmann, MD; Markus Kraemer, MD; and Jan Dörr, MD

2019 Drug and Device Approvals in Neurology image

Special Report

2019 Drug and Device Approvals in Neurology

Challenge Case Report: Aseptic Meningitis Worsening With Treatment image

Case Reports

Challenge Case Report: Aseptic Meningitis Worsening With Treatment

Diagnosis should be re-evaluated when clinical situations change.

David Horvat, MD, Jack Lovell, DO, and Glen Cook Jr, MD

Case Report: Seizure, Fever, Hallucinations, & Vision Loss image

Case Reports

Case Report: Seizure, Fever, Hallucinations, & Vision Loss

A circuitous route to dual diagnoses.

Elizabeth Carroll, MD; Asya I. Wallach, MD; Arielle Kurzweil, MD; Steven Frucht, MD; Thomas Berk, MD; Michael Boffa, MD; and Ilya Kister, MD

MS Minute: Oral Therapies for MS image

Columns

MS Minute: Oral Therapies for MS

The advent of oral therapies has ushered in a new phase of disease-modifying treatments.

Neeta Garg, MD, Micheline McCarthy, MD, PhD, and Ameeta Karmarkar, MD

This Month's Issue
Stroke Snapshot: Metabolic Stroke

Divakar Mithal, MD, PhD, and Tracy Gertler, MD, PhD

Child Neurology

Donna Stephenson, MD

Epilepsy Essentials: Metabolic Causes of Neonatal Seizures

Danielle S. Takacs, MD, and Eli M. Mizrahi, MD